Clik here to view.
Bidding war heats up for Toshiba Medical
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking...
View ArticleClik here to view.
Stryker to pay $1.3B for Physio-Control
Stryker (NYSE:SYK) said today that it agreed to pay $1.28 billion to Bain Capital for automated external defibrillator maker Physio-Control. Medtronic (NYSE:MDT) sold Physio-Control to Bain for $478...
View ArticleClik here to view.
Bain Capital raises $720m life sciences fund
Bain Capital said today that it raised $720 million for its 1st investment fund focused exclusively on the life sciences sector. “We are excited by some of the long-term secular trends in the life...
View ArticleClik here to view.
FLASH: Medtronic unloads Physio Control to Bain Capital for $478 million
Medtronic, Inc. (NYSE:MDT) agreed to sell its Physio-Control external defibrillator subsidiary to Bain Capital for roughly $478 million in cash. "Medtronic expects to use a portion of the proceeds to...
View ArticleClik here to view.
UPDATE: Medtronic finally unloads Physio-Control
Less than a month after new CEO Omar Ishrak signaled Medtronic’s (NYSE:MDT) continued interest in selling its troublesome Physio-Control resuscitation business, the company found a buy ready to put...
View ArticleClik here to view.
Physio-Control secures extension of $49M military contract
Physio-Control won an extension of its $49.4 million military contract with the U.S. Dept. of Defense for its automated external defibrillators and related accessories. The Redmond, Wash.-based...
View ArticleClik here to view.
Medtronic closes $478M Physio-Control sale to Bain Capital
Medtronic, Inc. (NYSE:MDT) today closed the sale of its Physio-Control defibrillator business to Bain Capital for $478 million in cash. The deal, first announced in November 2011, included the...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for January 30, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
MassDevice.com +7 | The top 7 med-tech stories for the week of January 29, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories...
View ArticleClik here to view.
Bidding war for Carestream heats up | Wall Street Beat
At least 5 major private equity players are vying for medical device company Carestream Health, including Bain Capital, Carlyle Group and KKR & Co., according to Reuters. Onex Corp. is hoping to...
View ArticleClik here to view.
Report: Private equity giants vie for Johnson & Johnson’s Ortho Clinical...
Johnson & Johnson (NYSE:JNJ) is mulling bids from some of the biggest names in private equity for its Ortho Clinical Diagnostics blood testing business, which the healthcare conglomerate put on...
View ArticleClik here to view.
Private equity shops battle for Philips’ legacy lighting biz
(Reuters) — A consortium of private equity firms CVC Capital Partners and Kohlberg Kravis Roberts put up the highest bid to take control of Royal Philips‘ (NYSE:PHG) legacy lighting business, though...
View ArticleClik here to view.
ZMH to float $7.7B debt to acquire Biomet | The week in medtech M&A
Zimmer to float $7.7B debt to acquire Biomet March 11, 2015 by Brad Perriello Zimmer said it agreed to float some $7.65 billion in senior notes to help finance its $13.35 billion buyout of cross-town...
View ArticleClik here to view.
Philips mulls 2016 IPO for lighting biz as bidding war heats up
Royal Philips (NYSE:PHG) yesterday said it’s considering an initial public offering next year for its legacy lighting business, even as it reviews bids from private equity shops and a new suitor from...
View ArticleClik here to view.
ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A
Report: EU to clear Zimmer's $13B Biomet deal March 18, 2015 by MassDevice Zimmer is set to secure conditional approval from European Union regulators for its proposed $13.35 billion takeover of rival...
View ArticleClik here to view.
CRM: BSX’s gain is STJ’s loss | Medtech Wall Street news for the week of...
CRM: Boston Scientific's gain is St. Jude Medical's loss March 20, 2015 by Brad Perriello FDA approval this week of the Emblem S-ICD made by Boston Scientific puts the company in place to take market...
View Article